Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Robert Swoboda is active.

Publication


Featured researches published by Robert Swoboda.


Bioorganic & Medicinal Chemistry | 1997

Combined Fmoc-Alloc strategy for a general SPPS of phosphoserine peptides; preparation of phosphorylation-dependent tau antisera

Gideon Shapiro; Dieter Büchler; Claudio Dalvit; Peter Frey; Maria del Carmen Fernández; Berta Gomez-Lor; Esteban Pombo-Villar; Urs Stauss; Robert Swoboda; Caroline Waridel

A block method for the solid phase synthesis (SPPS) of serine phosphopeptides has been developed using a combination of Fmoc and Alloc strategies. Alloc-Ser[PO(OCH2CH CH2)2] OH2, prepared in a one pot procedure from Alloc-Ser-OH, was introduced at the N-terminus of a sequence prepared by standard Fmoc-SPPS. Global cleavage of the allyl ester based protecting groups, followed by coupling of a tripeptide fragment, led to the tau phosphopeptide, 1. Using tau phosphopeptides a series of phosphorylation state-dependent antisera to human tau protein have been raised. These antisera are valuable tools for studying the tau protein which is found in an abnormal, hyperphosphorylated form in Alzheimers disease brain.


Bioorganic & Medicinal Chemistry Letters | 1996

COMBINED FMOC-ALLOC STRATEGY FOR A GENERAL SOLID PHASE SYNTHESIS OF PHOSPHOSERINE PEPTIDES

Gideon Shapiro; Dieter Büchler; Claudio Dalvit; Maria del Carmen Fernández; Berta Gomez-Lor; Esteban Pombo-Villar; Urs Stauss; Robert Swoboda

Abstract A building block method for the SPPS of serine phosphopeptides has been developed using a combination of Fmoc and Alloc strategies. Alloc-Ser[PO(OCH2CHCH2)2]-OH, prepared in a one-pot procedure from Alloc-Ser-OH, was introduced at the N-terminus of a sequence prepared by standard Fmoc-SPPS. Global cleavage of the allyl ester protecting groups followed by coupling of a tripeptide fragment led to tau phosphopeptide, 1, which was not available by post assembly phosphorylation strategies and is an important epitope of tau phosphoprotein in Alzheimer′s Disease. Fmoc SPPS ← Thr(tBu)-Glu(tBu)-Asn(Trt)-Leu-Lys(Boc)-His(Trt)-Wang + Alloc-Ser[PO(OAllyl)2]-OH ← ← H-Lys-Leu-Gly-Ser(P)-Thr-Glu-Asn-Leu-Lys-His-OH


Archive | 1997

Benzo[g]quinoline derivatives

Peter Neumann; Paul Pfaeffli; Max Peter Seiler; Robert Swoboda


Archive | 1998

Ergoline derivatives and their use as somatostatin receptor antagonists

Paul Pfaeffli; Peter Neumann; Robert Swoboda; Peter Stütz


Archive | 2000

Biphenyl derivatives as pharmaceuticals

Villar Esteban Pombo; Manuel Koller; Silvio Ofner; Robert Swoboda


Bioorganic & Medicinal Chemistry Letters | 2007

Identification and SAR of potent and selective non-peptide obeline somatostatin sst1 receptor antagonists.

Thomas J. Troxler; Daniel Hoyer; Daniel Langenegger; Peter Neumann; Paul Pfäffli; Philippe Schoeffter; Dieter Sorg; Robert Swoboda; Konstanze Hurth


Bioorganic & Medicinal Chemistry Letters | 2007

SAR of the arylpiperazine moiety of obeline somatostatin sst1 receptor antagonists

Konstanze Hurth; Albert Enz; Philipp Floersheim; Conrad Gentsch; Daniel Hoyer; Daniel Langenegger; Peter Neumann; Paul Pfäffli; Dieter Sorg; Robert Swoboda; Annick Vassout; Thomas J. Troxler


Archive | 1996

TETRALINES BEARING A PHENYL SUBSTITUANT ON THE AROMATIC RING AND THEIR USE IN THE TREATMENT OF EPILEPSY, STROKE AND BRAIN OR SPINAL TRAUMA

Robert Swoboda


Archive | 1999

Amino-tetralines, pharmaceutical compositions containing them and their pharmaceutical uses

Robert Swoboda


Archive | 1998

Derives d'ergoline

Paul Pfaeffli; Peter Neumann; Robert Swoboda; Peter Stütz

Collaboration


Dive into the Robert Swoboda's collaboration.

Researchain Logo
Decentralizing Knowledge